MENU
Immunicom Inc.

Immunicom Inc.

Updated April 2022.

92%

Employees say this is a great place to work


Company Overview

About The Company

Immunicom, Inc. is a privately held biotech company with a revolutionary platform to treat cancer. In contrast to treatments that add drugs to the body to fight cancer, Immunopheresis® is a subtractive therapy: it adds no drugs by treating patients with a plasma filtration cartridge. In a process like dialysis, the procedure is designed to activate the immune system to fight cancer while avoiding the toxicities and side effects of conventional treatments. Because of its non-pharmaceutical profile, Immunopheresis can be combined with any existing treatment, with the potential to markedly improve immune response and quality of life for cancer patients.

INDUSTRY

Health Care


Company Culture at Immunicom Inc.

The employee experience below at Immunicom Inc., compared to a typical company.

Learn More

92% of employees at Immunicom Inc. say it is a great place to work compared to 57% of employees at a typical U.S.-based company.

  • Immunicom Inc.
  • 92%
  • Typical Company
  • 57%
97%
I believe management would lay people off only as a last resort.
97%
Management is honest and ethical in its business practices.
97%
If I am unfairly treated, I believe I'll be given a fair shake if I appeal.
97%
People here are willing to give extra to get the job done.
97%
People here quickly adapt to changes needed for our organization's success.

Why Work at Immunicom Inc.?

See what employees say about what makes Immunicom Inc. a great workplace. These words are drawn from employee comments on the Trust Index™ survey.


Don't See Your Company Listed?

Nominate your company today to join Certification Nation

NOMINATE YOUR COMPANY